BioLight Life Sciences Ratios and Metrics

Market cap in millions ILS. Fiscal year is January - December.

Millions ILS. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 20, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	31	25	24	30	53	34
Market Cap Growth	45.08%	4.99%	-19.99%	-42.70%	53.43%	-9.45%
Enterprise Value	10	13	12	5	12	-16
Last Close Price	3.42	5.44	5.20	6.61	11.54	7.55
PE Ratio	-	-	-	-	137.74	-
PS Ratio	1474.76	115.64	204.41	478.54	17539.14	1106.27
PB Ratio	0.76	0.82	0.80	0.56	0.86	0.57
P/TBV Ratio	0.84	0.97	0.83	0.57	0.87	0.58
EV/Sales Ratio	-	58.93	104.02	86.87	4057.47	-
Debt / Equity Ratio	0.01	0.02	0.00	0.01	0.01	0.02
Net Debt / Equity Ratio	-0.60	-0.42	-0.28	-0.32	-0.54	-0.83
Net Debt / EBITDA Ratio	1.83	1.28	0.81	1.76	3.30	4.63
Net Debt / FCF Ratio	-	1.17	0.78	1.79	3.13	3.72
Asset Turnover	-	0.01	0.00	0.00	0	0
Quick Ratio	19.08	6.52	3.73	6.95	15.25	19.99
Current Ratio	19.08	6.94	3.91	7.11	15.38	20.09
Return on Equity (ROE)	-	-27.60%	-65.45%	-15.09%	-0.56%	-22.10%
Return on Assets (ROA)	-	-18.71%	-14.72%	-10.65%	-10.27%	-10.19%
Return on Invested Capital (ROIC)	-81.43%	-51.07%	-36.51%	-31.89%	-55.70%	-59.07%
Return on Capital Employed (ROCE)	-31.80%	-31.60%	-34.20%	-18.90%	-17.10%	-18.30%
Earnings Yield	-45.36%	-28.20%	-107.88%	-26.03%	0.73%	-39.02%
FCF Yield	-	-43.52%	-45.57%	-31.75%	-20.20%	-39.35%
Buyback Yield / Dilution	-3.47%	-0.29%	-1.70%	0.41%	-0.94%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.